CARDIAC SCIENCE INC

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Post-effective amendment to a registration statement

Certification of termination of registration of a class of securities (Section 12(g))

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

Written communication about a business combination transaction (Rule 425)

1.01,7.01,9.01

1.01,2.02,2.06,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

Other Events

Annual report pursuant to Section 13 or 15(d)

8.01,9.01

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

1.01,8.01,9.01

Results of Operations and Financial Condition

FILED AS OF DATE: 20050223

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

1.01

Annual report pursuant to Section 13 or 15(d) (amendment)

Definitive Proxy Statement

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

2.02,9.01

2.02,9.01

General form for quarterly reports under Section 13 or 15(d)

FILED AS OF DATE: 20040805

12,7

5,7

Beneficial ownership report for a holder of more than 5% (Schedule 13D) (amendment)

5

General form for quarterly reports under Section 13 or 15(d)

ITEM INFORMATION: Financial statements and exhibits

12,7

Annual report pursuant to Section 13 or 15(d)

12,7

7

Financial statements and exhibits

06

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

06

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Definitive Proxy Statement

Preliminary Proxy Statement

06

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d) (amendment)

No description available

General form for quarterly reports under Section 13 or 15(d)

Post-effective amendment filed solely to add exhibits

Post-effective amendment filed solely to add exhibits

No description available

No description available

General form for quarterly reports under Section 13 or 15(d)

No description available

General form for quarterly reports under Section 13 or 15(d) (amendment)

No description available

No description available

No description available

No description available

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

No description available

PEARL FRANK H

DE GREEF RODERICK

EVERS HOWARD

MATHUR PRABODH

LIN DONGPING

GIOFFREDI MICHAEL

O DONNELL JEFFREY SR

CROSBY PETER

BARCLAY BRUCE

COHEN RAYMOND W

DOVEY BRIAN H

PEARL FRANK H

COHEN RAYMOND W

PEARL FRANK H

PEARL FRANK H

SOHIE GUY

GIOFFREDI MICHAEL